Literature DB >> 11015310

Dual modulation by thrombin of the motility of rat oesophageal muscularis mucosae via two distinct protease-activated receptors (PARs): a novel role for PAR-4 as opposed to PAR-1.

A Kawabata1, R Kuroda, N Kuroki, H Nishikawa, K Kawai.   

Abstract

Since protease-activated receptors (PARs) are distributed throughout the gastrointestinal tract, we investigated the role of PARs in modulation of the motility of the rat oesophageal muscularis mucosae. Thrombin produced contraction of segments of the upper and lower part of the smooth muscle. Trypsin contracted both the muscle preparations only at high concentrations. SFLLR-NH(2) and TFLLR-NH(2) (PAR-1-activating peptides), but not the PAR-1-inactive peptide FSLLR-NH(2), evoked a marked contraction. In contrast, the PAR-2 agonist SLIGRL-NH(2) and the PAR-4 agonist GYPGKF-NH(2) caused no or only a negligible contraction. In oesophageal preparations precontracted with carbachol, thrombin produced a dual action i.e. relaxation followed by contraction. TFLLR-NH(2) further contracted the precontracted preparations with no preceding relaxation. GYPGKF-NH(2), but not the inactive peptide GAPGKF-NH(2), produced marked relaxation. Trypsin or SLIGRL-NH(2) caused no relaxation. The PAR-1-mediated contraction was completely abolished in Ca(2+)-free medium and considerably attenuated by nifedipine (1 microM) and in a low Na(+) medium. The PAR-4-mediated relaxation was resistant to tetrodotoxin (10 microM), apamin (0.1 microM), charybdotoxin (0.1 microM), L-N(G)-nitroarginine methyl ester (100 microM), indomethacin (3 microM), propranolol (5 microM) or adenosine 3', 5'-cyclic monophosphorothioate, 8-bromo, Rp-isomer (30 microM). Thus, thrombin plays a dual role in modulating the motility of the oesophageal muscularis mucosae, producing contraction via PAR-1 and relaxation via PAR-4. The PAR-1-mediated effect appears to occur largely through increased Na(+) permeability followed by activation of L-type Ca(2+) channels and subsequent influx of extracellular Ca(2+). Our data could provide evidence for a novel role of PAR-4 as opposed to PAR-1, although the underlying mechanisms are still open to question.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11015310      PMCID: PMC1572348          DOI: 10.1038/sj.bjp.0703590

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

Review 1.  Protease-activated receptors and platelet function.

Authors:  S R Coughlin
Journal:  Thromb Haemost       Date:  1999-08       Impact factor: 5.249

2.  Guinea pig platelets do not respond to GYPGKF, a protease-activated receptor-4-activating peptide: a property distinct from human platelets.

Authors:  H Nishikawa; A Kawabata; K Kawai; R Kuroda
Journal:  Blood Coagul Fibrinolysis       Date:  2000-01       Impact factor: 1.276

3.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.

Authors:  T K Vu; D T Hung; V I Wheaton; S R Coughlin
Journal:  Cell       Date:  1991-03-22       Impact factor: 41.582

4.  Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function.

Authors:  T R Faruqi; E J Weiss; M J Shapiro; W Huang; S R Coughlin
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

5.  Proteinase-activated receptor 4 (PAR4): action of PAR4-activating peptides in vascular and gastric tissue and lack of cross-reactivity with PAR1 and PAR2.

Authors:  M D Hollenberg; M Saifeddine; B Al-Ani; Y Gui
Journal:  Can J Physiol Pharmacol       Date:  1999-06       Impact factor: 2.273

6.  Proteinase-activated receptor-2 (PAR-2): regulation of salivary and pancreatic exocrine secretion in vivo in rats and mice.

Authors:  A Kawabata; H Nishikawa; R Kuroda; K Kawai; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 7.  Protease-activated receptor (PAR), a novel family of G protein-coupled seven trans-membrane domain receptors: activation mechanisms and physiological roles.

Authors:  A Kawabata; R Kuroda
Journal:  Jpn J Pharmacol       Date:  2000-03

8.  Modulation of airway smooth muscle tone by protease activated receptor-1,-2,-3 and -4 in trachea isolated from influenza A virus-infected mice.

Authors:  R S Lan; G A Stewart; P J Henry
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

9.  Role of the amino- and carboxyl-terminal domains of thrombin receptor-derived polypeptides in biological activity in vascular endothelium and gastric smooth muscle: evidence for receptor subtypes.

Authors:  M D Hollenberg; A A Laniyonu; M Saifeddine; G J Moore
Journal:  Mol Pharmacol       Date:  1993-06       Impact factor: 4.436

10.  Proteinase-activated receptor 2 (PAR2)-activating peptides: identification of a receptor distinct from PAR2 that regulates intestinal transport.

Authors:  N Vergnolle; W K Macnaughton; B Al-Ani; M Saifeddine; J L Wallace; M D Hollenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

View more
  11 in total

Review 1.  Protease-activated receptor 4: a critical participator in inflammatory response.

Authors:  Qiang Fu; Jing Cheng; Yebo Gao; Yonglei Zhang; Xiaobing Chen; Jianguo Xie
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

2.  The expression of protease-activated receptor 2 and 4 in the colon of irritable bowel syndrome patients.

Authors:  Ju-hui Zhao; Lei Dong; Hai-tao Shi; Zong-yan Wang; Hong-yang Shi; Hui Ding
Journal:  Dig Dis Sci       Date:  2011-07-29       Impact factor: 3.199

3.  In vivo evidence that protease-activated receptors 1 and 2 modulate gastrointestinal transit in the mouse.

Authors:  A Kawabata; R Kuroda; N Nagata; N Kawao; T Masuko; H Nishikawa; K Kawai
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

4.  Dual effect mediated by protease-activated receptors on the mechanical activity of rat colon.

Authors:  Flavia Mulè; Maria Carmela Baffi; Maria Carmela Cerra
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

Review 5.  Gastrointestinal roles for proteinase-activated receptors in health and disease.

Authors:  A Kawabata; M Matsunami; F Sekiguchi
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

6.  Evidence for the presence of functional protease activated receptor 4 (PAR4) in the rat colon.

Authors:  F Mulè; R Pizzuti; A Capparelli; N Vergnolle
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

7.  Involvement of nitric oxide and tachykinins in the effects induced by protease-activated receptors in rat colon longitudinal muscle.

Authors:  Flavia Mulè; Maria Carmela Baffi; Anna Capparelli; Roberta Pizzuti
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

Review 8.  Modulation of visceral pain and inflammation by protease-activated receptors.

Authors:  Nathalie Vergnolle
Journal:  Br J Pharmacol       Date:  2004-03-29       Impact factor: 8.739

9.  Impairment of PAR-2-mediated relaxation system in colonic smooth muscle after intestinal inflammation.

Authors:  Koichi Sato; Hiromichi Ninomiya; Shinsuke Ohkura; Hiroshi Ozaki; Tetsuyuki Nasu
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

10.  Protease-activated receptor-4: a novel mechanism of inflammatory pain modulation.

Authors:  S Asfaha; N Cenac; S Houle; C Altier; M D Papez; C Nguyen; M Steinhoff; K Chapman; G W Zamponi; N Vergnolle
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.